Protein tyrosine phosphatase 2 (Shp2) activation in the BMSC upregulates VCAM-1 expression through activating the PI3K/AKT signalling pathway, which thereby interacts with VLA-4 in B-ALL cells to resist vincristine. This evidence concerns the gene VCAM1 and acute lymphoblastic leukemia.